|
Jul 31
|
493 employees laid off at biopharmaceutical company with operations in Andover
|
|
Jul 31
|
George Tidmarsh to sub in as FDA CBER head following Prasad’s shock exit
|
|
Jul 31
|
Arrowhead Pharmaceuticals, Inc. (ARWR) Secures $100M Milestone from Sarepta in RNAi Breakthrough Deal
|
|
Jul 31
|
Will Insmed (INSM) Report Negative Earnings Next Week? What You Should Know
|
|
Jul 31
|
Sarepta Therapeutics to Announce Second Quarter 2025 Financial Results
|
|
Jul 31
|
Markets Are Being Driven by AI, Not the Fed. Where Stocks Go From Here.
|
|
Jul 30
|
Top FDA Official’s Surprise Departure Means More Uncertainty for Biotech
|
|
Jul 30
|
Sarepta Therapeutics (SRPT) to Report Q2 Results: Wall Street Expects Earnings Growth
|
|
Jul 29
|
Sarepta Therapeutics, Inc. (SRPT): “You Don’t Court Homicide,” Says Jim Cramer
|
|
Jul 29
|
These Stocks Are Moving the Most Today: SoFi, UnitedHealth, PayPal, Merck, Novo Nordisk, UPS, Sarepta, Boeing, Norfolk Southern, and More
|
|
Jul 29
|
Sarepta Therapeutics Set to Trade Higher With Elevidys Back on Market, Oppenheimer Says
|
|
Jul 29
|
Sarepta Stock Soars After FDA Says It Can Resume Drug Shipments
|
|
Jul 29
|
PayPal, Sarepta, JetBlue: Trending Tickers
|
|
Jul 29
|
Sarepta Therapeutics Stock Surges as FDA Allows Elevidys Sales to Resume
|
|
Jul 29
|
Vor Biopharma (VOR) Jumps 10% on Addition of 2 CEOs to Board
|
|
Jul 29
|
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
|
|
Jul 29
|
Sarepta can begin shipping Elevidys therapy after FDA reverses pause, stock soars
|
|
Jul 29
|
Sarepta Stock Just Soared 40%. Here’s Why.
|
|
Jul 29
|
Trending tickers: Nvidia, Sarepta, Spotify, AstraZeneca and Greggs
|
|
Jul 28
|
Sarepta will resume gene therapy shipments after FDA review of recent patient death
|